<DOC>
	<DOCNO>NCT02307591</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety amiodarone treatment patient afflict Ebola virus disease .</brief_summary>
	<brief_title>Clinical Study Assess Efficacy Safety Amiodarone Treating Patients With Ebola . Virus Disease ( EVD ) Sierra Leone . EASE ( EMERGENCY Amiodarone Study Against Ebola )</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Hemorrhagic Fever , Ebola</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>patient admit Emergency ETC Goderich clinical diagnosis Ebola virus disease ; patient consent participate study . negative RTPCR test Ebola virus age &lt; 2 year state shock upon admission onset fever 6 day Glasgow Coma Scale &lt; 12 know contraindication administration amiodarone positive HIV antibody .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>